
The Childhood Meningitis Disease Younger Parents Rarely Hear About: Hib
There is a vaccine on the infant schedule with a name many parents barely recognize: Hib.
That unfamiliarity is actually part of the success story.
What pediatric care used to look like
Before effective Hib vaccines, Haemophilus influenzae type b was the leading cause of bacterial meningitis in U.S. children younger than five.
About 20,000 young children developed serious invasive Hib disease each year. Roughly 12,000 of those cases were meningitis, and invasive disease could also cause bloodstream infection, pneumonia, epiglottitis, septic arthritis, permanent neurologic injury, and death.
The risk was concentrated in very young children—the same age group we now vaccinate beginning in infancy.
Then the disease nearly disappeared
Hib conjugate vaccines were introduced in the late 1980s and recommended routinely for infants in 1990.
Within only a few years, invasive Hib disease in young children declined by more than 95%.
That is why many younger clinicians and parents have never personally seen a classic case of Hib meningitis or epiglottitis.
What this means in Wahiawa
When we review an infant vaccine record at Central Health, Hib may be one of the least familiar names on the page.
But a generation ago, pediatricians knew this bacterium extremely well.
Sometimes the diseases people worry least about are the ones vaccination pushed furthest out of everyday life.
— Nora Phillips, DNP, APRN Central Health | Wahiawa, Hawaii
Sources
CDC — Types of Hib Vaccines. https://www.cdc.gov/hi-disease/vaccines/types.html
CDC — Progress Toward Elimination of Hib Disease, 1987–1995. https://www.cdc.gov/mmwr/preview/mmwrhtml/00044142.htm



Comments